Streetbeat News

Stock Prices

AMAM

Ambrx Biopharma's shares (AMAM) are set to resume trading at 8:00 a.m. after a halt. This could indicate significant news pending or recently released that could impact the stock's performance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:58 pm

AMAM

Trading for AMAM has resumed after a halt status update at 7:55:00 AM ET. The halt was related to news dissemination, and the stock has now begun trading again with updated quotations.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:55 pm

LAUR

MODN

OPEN

Insiders at Opendoor Technologies, Model N, RH, and Laureate Education have recently sold shares of their companies. Opendoor's President sold shares after a price target increase by JMP Securities. Model N's Chief Services Officer sold shares following a downgrade by JP Morgan. An insider at RH sold shares after the company reported disappointing Q3 results. Laureate Education's 10% owner sold shares post the company's upbeat quarterly results. Insider sales can indicate various sentiments and should not be the sole basis for investment decisions.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 12:54 pm

SPWR

Wells Fargo analyst Michael Blum has downgraded SunPower (NASDAQ:SPWR) from Equal-Weight to Underweight and reduced the price target from $6 to $4, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:53 pm

TROW

Wells Fargo analyst Finian O'Shea has downgraded T. Rowe Price Gr (TROW) from Equal-Weight to Underweight, while also raising the price target from $95 to $105. This reflects a more bearish stance on the company's stock, despite the increased price target.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:48 pm

MRNA

Moderna provided updates at the J.P. Morgan Healthcare Conference, projecting 2023 product sales of around $6.7B. The company's U.S. COVID-19 market share has risen to 48% in 2023 from 37% in 2022. Moderna reaffirmed its 2024 sales forecast of $4B, with a return to sales growth expected in 2025 and a break-even point anticipated in 2026 due to new product launches and disciplined investment.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:46 pm

ULCC

Morgan Stanley analyst Ravi Shanker has downgraded Frontier Group Holdings (NASDAQ:ULCC) from Overweight to Equal-Weight and reduced the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:45 pm

LLAP

B. Riley Securities analyst Mike Crawford has downgraded Terran Orbital (NYSE:LLAP) from Buy to Neutral and reduced the price target from $2.5 to $1.35.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:44 pm

ANGO

AON

BEN

COIN

DELL

HOOD

ICE

MBLY

UPWK

Wall Street analysts have updated their price targets and ratings for several US-listed companies. Needham raised Coinbase's target from $160 to $180 with a Buy rating. JP Morgan upgraded Aon from Neutral to Overweight, cutting the target from $351 to $321. Jefferies upgraded Upwork from Hold to Buy, raising the target from $13 to $20. HC Wainwright maintained a Buy on AngioDynamics but lowered the target from $20 to $18. Wells Fargo upgraded Franklin Resources to Equal-Weight, increasing the target from $24 to $30. JP Morgan upgraded Dell to Overweight, raising the target from $77 to $90. Barclays upgraded Intercontinental Exchange to Overweight, boosting the target from $120 to $148. Keybanc maintained an Overweight on Robinhood, increasing the target from $12 to $14. Keybanc also maintained an Overweight on Visa, raising the target from $275 to $300. Lastly, Raymond James maintained an Outperform on Mobileye Global but cut the target from $48 to $40.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 12:42 pm

BABA

BIDU

NVDA

TCEHY

Nvidia Corp (NVDA) faces challenges in the Chinese market due to U.S. regulations barring high-performance AI chip sales. Major Chinese cloud companies like Alibaba (BABA) and Tencent (TCEHY) plan to reduce Nvidia chip orders, turning to local alternatives and in-house developments. Baidu (BIDU) and ByteDance are also shifting towards domestic producers like Huawei. Despite this, Nvidia sold over $1 billion of modified chips in China in 2023 and is developing new AI chips like the H20 for the Chinese market, set for production in Q2 2024. Nvidia's stock saw a slight increase on Monday.

Portfolio Pulse from Anusuya Lahiri

January 08, 2024 | 12:40 pm